Unknown PHASE4 INTERVENTIONAL 3-arm NCT02201914

Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF

Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF: a Randomized Study

Sponsor: Bioroma

Conditions Clomiphene Citrate GnRH Agonist GnRH Antagonist IVF Poor Responders

Interventions Clomiphene citrate Daily FSH and LH plus Cetrorelix Triptorelin plus daily FSH anh LH

Updated 5 times since 2017 Last updated: Jul 24, 2014 Started: Jan 31, 2014 Primary completion: Oct 31, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Clomiphene Citrate and GnRH Agonist, this trial is ongoing. The trial is conducted by Bioroma and has accumulated 5 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bioroma

Data source: Bioroma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy